Fletcher Aaron G.L.'s Form 4 filing
Cue Biopharma, Inc. (CUE) · filed May 25, 2022
- Accession no.
- 0001209191-22-031791
- Filed
- May 25, 2022
- Trade date
- May 23-24, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $711.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Fletcher Aaron G.L.CIK 0001789490 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2022 | Common Stock | PPurchaseAcquired | +150,000 | $3.52 | +$528,000 | 885,000 | Indirect | |
| May 24, 2022 | Common Stock | PPurchaseAcquired | +55,000 | $3.34 | +$183,700 | 940,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.